Evidence map›Paper›PMID 41801269›Full record

ReviewIntensive care medicine2026

Feeding the injured brain: nutrients, dose, timing, and monitoring.

Yaseen M Arabi, Christian Stoppe, Michael P Casaer, Emma J Ridley, Jean Reignier, Hasan M Al-Dorzi, Filippo Annoni, Jean-Charles Preiser

Abstract readReview
PubMed Publisher
In one paragraph

Review in Intensive care medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yaseen M ArabiIntensive Care Department, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. yaseenarabi@yahoo.com.ORCID 0000-0001-5735-6241
Christian StoppeDepartment of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital, Würzburg, Germany.ORCID 0000-0002-2028-2039
Michael P CasaerClinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven and UZ Leuven, Louvain, Belgium.ORCID 0000-0002-7087-0795
Emma J RidleyAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.ORCID 0000-0002-7922-5717
Jean ReignierMedical Intensive Care Unit, Nantes Université, CHU Nantes, Movement - Interactions - Performance (MIP), Nantes University Hospital, Nantes, France.ORCID 0000-0002-3768-3496
Hasan M Al-DorziIntensive Care Department, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.ORCID 0000-0002-3772-8949
Filippo AnnoniDepartment of Intensive Care, University Hospital of Brussels (HUB), Université Libre de Bruxelles, Anderlecht, Belgium.ORCID 0000-0002-1271-9034
Jean-Charles PreiserDepartment of Internal Medicine, University Hospital of Brussels (HUB), Université Libre de Bruxelles, Anderlecht, Belgium.ORCID 0000-0003-3163-0390

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutrition is a key component of the management of neurocritically ill patients. The healthy brain accounts for up to 25% of total resting energy expenditure (REE), and after injury the brain faces inflammation, altered glucose metabolism, and catabolic stress. This review outlines the evolving science and current practice of nutrition in neurocritical illness, emphasizing pathophysiology, metabolic phases, and individualized strategies. Enteral nutrition remains the preferred route, with early, low-dose initiation within 24-48 h generally recommended. Feeding intolerance, aspiration risk, and altered gastrointestinal motility are common barriers. Parenteral nutrition may be warranted when enteral nutrition is contraindicated or insufficient; however, early initiation of target feeding, independent of the enteral or parenteral route of administration, has shown harm in general ICU populations and remains underexplored in neurocritically ill patients. The role of timing to start feeding, energy and protein dosing, micronutrient supplementation, and metabolic monitoring via indirect calorimetry is discussed, with recent trials questioning traditional targets. Emerging concepts include the ketogenic diet, exogenous lactate, and immunonutrition, all of which aim to optimize recovery and reduce secondary brain injury. Despite promising mechanistic rationale, robust neurocritical-specific data are lacking. Personalized nutrition based on metabolic phenotyping and real-time monitoring to optimize neurocritical nutrition requires further validation. Ultimately, nutritional care in neurocritical settings might benefit from a multidisciplinary integrated approach. Rather than supportive care alone, nutrition could be viewed as a modifiable therapeutic intervention with the potential to influence neurological recovery and long-term outcomes.

Indexed as

Brain InjuriesEnteral NutritionCritical CareCritical IllnessEnergy MetabolismHumansParenteral NutritionTime FactorsBrain injuryCritical careEnergy metabolismEnteral nutritionParenteral nutrition

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.